THE EFFECT OF TREATMENT ON THE INFLAMMATION PROFILE AMONG PATIENTS WITH PRIMARY ALDOSTERONISM

被引：0
|
作者：
Kantauskaite, Marta [1 ]
Duvnjak, Blanka [1 ]
Schmidt, Claudia [1 ]
Koenigshausen, Eva [1 ]
Zierhut, Ulf [1 ]
Rump, Lars Christian [1 ]
Stegbauer, Johannes [1 ]
机构：
[1] Heinrich Heine Univ, Univ Clin Dusseldorf, Dept Nephrol, Dusseldorf, Germany
来源：
JOURNAL OF HYPERTENSION | 2024年 / 42卷
关键词：
D O I：
10.1097/01.hjh.0001019752.20938.34
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Treatment of primary aldosteronism
    Quinkler, Marcus
    Stewart, Paul M.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 24 (06) : 923 - 932
  • [22] Prevalence of glucocorticoid-remediable aldosteronism among newly diagnosed patients with primary aldosteronism
    Widimsky, J., Jr.
    Lacinova, Z.
    Zelinka, T.
    Dvorakova, J.
    Zogala, D.
    Strauch, B.
    Petrak, O.
    Holaj, R.
    Seeman, T.
    Hampf, M.
    Bernhardt, R.
    JOURNAL OF HYPERTENSION, 2006, 24 : S358 - S358
  • [23] PRIMARY ALDOSTERONISM: THE EFFECT OF SPECIFIC TREATMENT ON RENAL FUNCTION
    Concistre, Antonio
    Petramala, Luigi
    Della Ricca, Ilaria
    Servello, Adriana
    Circosta, Francesco
    Cavallaro, Giuseppe
    Letizia, Claudio
    JOURNAL OF HYPERTENSION, 2023, 41 : E205 - E205
  • [24] Arterial Wall Inflammation and Increased Hematopoietic Activity in Patients With Primary Aldosteronism
    van der Heijden, Charlotte D. C. C.
    Smeets, Esther M. M.
    Aarntzen, Erik H. J. G.
    Noz, Marlies P.
    Monajemi, Houshang
    Kersten, Simone
    Kaffa, Charlotte
    Hoischen, Alexander
    Deinum, Jaap
    Joosten, Leo A. B.
    Netea, Mihai G.
    Riksen, Niels P.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (05):
  • [25] PRIMARY ALDOSTERONISM: THE EFFECT OF SPECIFIC TREATMENT ON RENAL FUNCTION
    Concistre, Antonio
    Petramala, Luigi
    Della Ricca, Ilaria
    Servello, Adriana
    Circosta, Francesco
    Cavallaro, Giuseppe
    Letizia, Claudio
    JOURNAL OF HYPERTENSION, 2023, 41 : E25 - E25
  • [26] Long-term effects of primary aldosteronism treatment on patients with primary aldosteronism and chronic kidney disease
    Nakano, Yujiro
    Murakami, Masanori
    Hara, Kazunari
    Fukuda, Tatsuya
    Horino, Masato
    Takeuchi, Akira
    Niitsu, Yoshihiro
    Shiba, Kumiko
    Tsujimoto, Kazutaka
    Komiya, Chikara
    Yokoyama, Minato
    Ikeda, Kenji
    Yoshimoto, Takanobu
    Fujii, Yasuhisa
    Yamada, Tetsuya
    CLINICAL ENDOCRINOLOGY, 2023, 98 (03) : 323 - 331
  • [27] Cardiovascular outcomes in patients with primary aldosteronism after treatment
    Catena, Cristiana
    Colussi, GianLuca
    Nadalini, Elisa
    Chiuch, Alessandra
    Baroselli, Sara
    Lapenna, Roberta
    Sechi, Leonardo A.
    ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (01) : 80 - 85
  • [28] Effect of short-term losartan treatment in patients with primary aldosteronism and essential hypertension
    Zacharieva, S
    Atanassova, I
    Natchev, E
    Orbetzova, M
    Tzingilev, D
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (03): : 153 - 156
  • [29] Prevalence of primary aldosteronism among patients with type 2 diabetes
    Tancredi, Mauro
    Johannsson, Gudmundur
    Eliasson, Bjorn
    Eggertsen, Robert
    Lindblad, Ulf
    Dahlqvist, Sofia
    Imberg, Henrik
    Lind, Marcus
    CLINICAL ENDOCRINOLOGY, 2017, 87 (03) : 233 - 241
  • [30] Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore
    Loh, KC
    Koay, ES
    Khaw, MC
    Emmanuel, SC
    Young, WF
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (08): : 2854 - 2859
12345